These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21688653)

  • 21. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption.
    Neumann MA; Laster MJ; Weiskopf RB; Gong DH; Dudziak R; Förster H; Eger EI
    Anesth Analg; 1999 Sep; 89(3):768-73. PubMed ID: 10475323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Various reactions of sevoflurane with the individual components of soda lime].
    Förster H; Warnken UH; Asskali F
    Anaesthesist; 1997 Dec; 46(12):1071-5. PubMed ID: 9451491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans.
    Mchaourab A; Arain SR; Ebert TJ
    Anesthesiology; 2001 Jun; 94(6):1007-9. PubMed ID: 11465591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of volatile sevoflurane degradation product formation in an anesthesia circuit by a reduction in soda lime temperature.
    Ruzicka JA; Hidalgo JC; Tinker JH; Baker MT
    Anesthesiology; 1994 Jul; 81(1):238-44. PubMed ID: 8042791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers.
    Ebert TJ; Frink EJ; Kharasch ED
    Anesthesiology; 1998 Mar; 88(3):601-10. PubMed ID: 9523801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting production of compound A from the interaction of sevoflurane with Baralyme and soda lime.
    Fang ZX; Kandel L; Laster MJ; Ionescu P; Eger EI
    Anesth Analg; 1996 Apr; 82(4):775-81. PubMed ID: 8615497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of compound A under low-flow anesthesia is affected by type of anesthetic machine.
    Yamakage M; Kimura A; Chen X; Tsujiguchi N; Kamada Y; Namiki A
    Can J Anaesth; 2001 May; 48(5):435-8. PubMed ID: 11394509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of carbon monoxide during routine anesthetics in infants and children.
    Levy RJ; Nasr VG; Rivera O; Roberts R; Slack M; Kanter JP; Ratnayaka K; Kaplan RF; McGowan FX
    Anesth Analg; 2010 Mar; 110(3):747-53. PubMed ID: 20185653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The loss of sevoflurane from a closed breathing system.
    Vagts DA; Lockwood GG
    Anaesthesia; 1997 Jul; 52(7):636-9. PubMed ID: 9244020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanisms of carbon monoxide production by inhalational agents.
    Coppens MJ; Versichelen LF; Rolly G; Mortier EP; Struys MM
    Anaesthesia; 2006 May; 61(5):462-8. PubMed ID: 16674622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers.
    Ebert TJ; Messana LD; Uhrich TD; Staacke TS
    Anesth Analg; 1998 Mar; 86(3):662-7. PubMed ID: 9495434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic and Environmental Considerations During Low Fresh Gas Flow Volatile Agent Administration After Change to a Nonreactive Carbon Dioxide Absorbent.
    Epstein RH; Dexter F; Maguire DP; Agarwalla NK; Gratch DM
    Anesth Analg; 2016 Apr; 122(4):996-1006. PubMed ID: 26735317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soda lime temperatures during low-flow sevoflurane anaesthesia and differences in dead-space.
    Luttropp HH; Johansson A
    Acta Anaesthesiol Scand; 2002 May; 46(5):500-5. PubMed ID: 12027842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of four carbon dioxide absorbents in experimental and clinical settings.
    Yamakage M; Takahashi K; Takahashi M; Satoh JI; Namiki A
    Anaesthesia; 2009 Mar; 64(3):287-92. PubMed ID: 19302642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts.
    Morio M; Fujii K; Satoh N; Imai M; Kawakami U; Mizuno T; Kawai Y; Ogasawara Y; Tamura T; Negishi A
    Anesthesiology; 1992 Dec; 77(6):1155-64. PubMed ID: 1466466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel radiator for carbon dioxide absorbents in low-flow anesthesia.
    Hirabayashi G; Mitsui T; Kakinuma T; Ogihara Y; Matsumoto S; Isshiki A; Yasuo W
    Ann Clin Lab Sci; 2003; 33(3):313-9. PubMed ID: 12956447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Kidney function in test subjects: published results and clinical relevance].
    Frink EJ
    Anaesthesist; 1998 Nov; 47 Suppl 1():S33-6. PubMed ID: 9893878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The compound A concentration in a low-flow anesthesia circuit using the new CO2 absorbent SPHERASORB].
    Obata R; Bito H; Katoh T; Sato S
    Masui; 2000 May; 49(5):504-8. PubMed ID: 10846381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of low-flow sevoflurane anesthesia in patients with chronically impaired renal function is not proven.
    Saidman LJ; Eger EI
    Anesthesiology; 2003 Sep; 99(3):752; author reply 752-4. PubMed ID: 12960564
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal toxicity with sevoflurane: a storm in a teacup?
    Gentz BA; Malan TP
    Drugs; 2001; 61(15):2155-62. PubMed ID: 11772127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.